Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Functional changes of Vγ9/Vδ 2 T lymphocytes in BD patients and controls

From: Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity

  Active BD Inactive BD Controls P
EF of Vγ9/Vδ2 295 ± 44 36 ± 8 30 ± 8 < 0.0001
Vγ9/Vδ 2 TNF-RII 10,422 ± 1,694 4,087 ± 1.671 4,512 ± 1436 < 0.0001
IFN-γ (% of Vγ9/Vδ 2) 40.4 ± 8.2 18 ± 7 11 ± 4 < 0.001
Perforin (mOD units) 27,581 ± 4.611 5,247 ± 1,230 4,980 ± 1,110 < 0.001
Granzyme A (mOD units) 818 ± 97 589 ± 21 550 ± 30 < 0.05
  1. BD: Behçet's disease; EF: Expansion factor.